Photo of Judith Lin

Judith Lin

  • ASSISTANT PROFESSOR Medicine, Hematology and Medical Oncology
Print ProfilePrint Profile

Clinical Focus

  • Coagulation Disorders
  • Hematology
  • Paroxysmal Nocturnal Hemoglobinuria (PNH)


  • Hematology

  • American Board of Internal Medicine


  • MD, SUNY at Stony Brook School of Medicine

  • Internship, Internal Medicine
    University of Southern California Med Center

  • Residency, Internal Medicine
    Mount Sinai Hospital

  • Residency, Internal Medicine
    University of Southern California Med Center

  • Fellowship, Hematology
    University of Southern California Med Center

  • Fellowship, Hematology
    Orthopaedic Hospital


  • -
    Teaching Award
    University of Southern California + Los Angeles County Medical Center

  • 2013 -
    Hematopathology Teaching Award
    Brigham & Women's Hospital, Boston, MA

  • 2000 - 2003
    Howard Hughes Medical Institute Physician Postdoctoral Fellowship



Bleeding disorders, thrombotic disorders, red blood cell and platelet disorders including immune thrombocytopenia, microangiopathic thrombotic microangiopathies (TTP, HUS, atypical HUS), immune mediated disorders (autoimmune hemolytic anemias), hemophagocytic disorders, acquired factor VIII inhibitors, amyloid associated bleeding disorders, non-malignant hematology.


Lane J, McLaren PJ, Dorrell L, Shianna KV, Stemke A, Pelak K, Moore S, Oldenburg J, Alvarez-Roman MT, Angelillo-Scherrer A, Boehlen F, Bolton-Maggs PH, Brand B, Brown D, Chiang E, Cid-Haro AR, Clotet B, Collins P, Colombo S, Dalmau J, Fogarty P, Giangrande P, Gringeri A, Iyer R, Katsarou O, Kempton C, Kuriakose P, Lin J, Makris M, Manco-Johnson M, Tsakiris DA, Martinez-Picado J, Mauser-Bunschoten E, Neff A, Oka S, Oyesiku L, Parra R, Peter-Salonen K, Powell J, Recht M, Shapiro A, Stine K, Talks K, Telenti A, Wilde J, Yee TT, Wolinsky SM, Martinson J, Hussain SK, Bream JH, Jacobson LP, Carrington M, Goedert JJ, Haynes BF, McMichael AJ, Goldstein DB, Fellay J. A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A. Human molecular genetics 2013 May; 22(9).

Lalezari S, Coppola A, Lin J, Enriquez MM, Tseneklidou-Stoeter D, Powell J, Ingerslev J. Patient characteristics that influence efficacy of prophylaxis with rFVIII-FS three times per week: a subgroup analysis of the LIPLONG study. Haemophilia : the official journal of the World Federation of Hemophilia 2014 May; 20(3).

Coyle TE, Reding MT, Lin JC, Michaels LA, Shah A, Powell J. Phase I study of BAY 94-9027, a PEGylated B-domain-deleted recombinant factor VIII with an extended half-life, in subjects with hemophilia A. Journal of thrombosis and haemostasis : JTH 2014 Apr; 12(4).

Mahlangu J, Powell JS, Ragni MV, Chowdary P, Josephson NC, Pabinger I, Hanabusa H, Gupta N, Kulkarni R, Fogarty P, Perry D, Shapiro A, Pasi KJ, Apte S, Nestorov I, Jiang H, Li S, Neelakantan S, Cristiano LM, Goyal J, Sommer JM, Dumont JA, Dodd N, Nugent K, Vigliani G, Luk A, Brennan A, Pierce GF. Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A. Blood 2014 Jan; 123(3).

Kasper CK, Lin JC. How many carriers are there?. Haemophilia : the official journal of the World Federation of Hemophilia 2010 Sep; 16(5).

Kasper CK, Lin JC. Prevalence of sporadic and familial haemophilia. Haemophilia : the official journal of the World Federation of Hemophilia 2007 Jan; 13(1).

Nikolov DB, Hu SH, Lin J, Gasch A, Hoffmann A, Horikoshi M, Chua NH, Roeder RG, Burley SK. Crystal structure of TFIID TATA-box binding protein. Nature 1992 Nov; 360(6399).

Kayali AG, Goodman MN, Lin J, Young VR. Insulin- and thyroid hormone-independent adaptation of myofibrillar proteolysis to glucocorticoids. The American journal of physiology 1990 Nov; 259(5 Pt 1).

Lin JC, Borregaard N, Liebman HA, Carmel R. Deficiency of the specific granule proteins, R-binder/transcobalamin I and lactoferrin, in plasma and saliva: a new disorder. American journal of medical genetics 2001 Apr; 100(2).

Li J, Lin JC, Wang H, Peterson JW, Furie BC, Furie B, Booth SL, Volpe JJ, Rosenberg PA. Novel role of vitamin k in preventing oxidative injury to developing oligodendrocytes and neurons. The Journal of neuroscience : the official journal of the Society for Neuroscience 2003 Jul; 23(13).

Industry Relationships

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.

Dr. Lin did not report having any of the following types of financial relationships with industry during 2015 and/or 2016: consulting, scientific advisory board, industry-sponsored lectures, service on Board of Directors, participation on industry-sponsored committees, equity ownership valued at greater than 5% of a publicly traded company or any value in a privately held company. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.

Insurance Information

Physicians who provide services at hospitals and facilities in the Mount Sinai Health System might not participate in the same health plans as those Mount Sinai hospitals and facilities (even if the physicians are employed or contracted by those hospitals or facilities).

Information regarding insurance participation and billing by this physician may be found on this page, and can also be obtained by contacting this provider directly. Because physicians insurance participation can change, the insurance information on this page may not always be up-to-date. Please contact this physician directly to obtain the most up-to-date insurance information.

Insurance and health plan networks that the various Mount Sinai Health System hospitals and facilities participate in can be found on the Mount Sinai Health System website.

Edit profile in Sinai Central


Residential Tower Floor 2 Room R2-503
10 East 102nd Street
New York, NY 10029

Tel: 212-241-6756
Fax: 646-537-9639
Ruttenberg Treatment Center

1470 Madison Avenue
3rd Floor
New York, NY 10029

Tel: 212-241-6756
Fax: 646-537-9639
Get Directions

Office Hours:
  • Monday 8:00am - 5:00pm
  • Tuesday 10:00am - 3:00pm
  • Friday 1:00pm - 4:00pm
Insurance Plans
  • 1199
  • Access Medicare
  • Aetna
  • Affinity
  • Amerigroup
  • AmidaCare
  • Cigna - HMO
  • Empire Blue Cross/Blue Shield - PPO
  • Fidelis Medicare
  • GHI
  • Health Insurance Plan (HIP)
  • Healthfirst
  • Humana
  • Island Group
  • Magnacare
  • Medicaid of New York
  • Medicare
  • MetroPlus Health Plan
  • MultiPlan, Inc.
  • Oxford Health Plans
  • Pomco
  • United Healthcare
  • VNS Medicare
  • WellCare of New York, Inc.
Payment Methods
  • Master Card
  • Visa
  • American Express
  • Discover
  • Personal Check
  • Cash